285 related articles for article (PubMed ID: 28152535)
21. Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.
Dahrouj M; Alsarraf O; McMillin JC; Liu Y; Crosson CE; Ablonczy Z
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2269-75. PubMed ID: 24550368
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
23. Agreement between OCT Leakage and Fluorescein Angiography to Identify Sites of Alteration of the Blood-Retinal Barrier in Diabetes.
Cunha-Vaz J; Santos T; Alves D; Marques I; Neves C; Soares M; Lobo C
Ophthalmol Retina; 2017; 1(5):395-403. PubMed ID: 31047568
[TBL] [Abstract][Full Text] [Related]
24. Macular edema: definition and basic concepts.
Coscas G; Cunha-Vaz J; Soubrane G
Dev Ophthalmol; 2010; 47():1-9. PubMed ID: 20703040
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.
Ozaki H; Hayashi H; Vinores SA; Moromizato Y; Campochiaro PA; Oshima K
Exp Eye Res; 1997 Apr; 64(4):505-17. PubMed ID: 9227268
[TBL] [Abstract][Full Text] [Related]
27. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema.
Yeung L; Lima VC; Garcia P; Landa G; Rosen RB
Ophthalmology; 2009 Jun; 116(6):1158-67. PubMed ID: 19395034
[TBL] [Abstract][Full Text] [Related]
28. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
29. One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy.
Lobo CL; Bernardes RC; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2001 Oct; 119(10):1469-74. PubMed ID: 11594946
[TBL] [Abstract][Full Text] [Related]
30. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.
Kaur C; Foulds WS; Ling EA
Prog Retin Eye Res; 2008 Nov; 27(6):622-47. PubMed ID: 18940262
[TBL] [Abstract][Full Text] [Related]
31. Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema.
Campos A; Campos EJ; Martins J; Ambrósio AF; Silva R
Acta Ophthalmol; 2017 Aug; 95(5):446-459. PubMed ID: 27545332
[TBL] [Abstract][Full Text] [Related]
32. Roles of Drug Transporters in Blood-Retinal Barrier.
Liu L; Liu X
Adv Exp Med Biol; 2019; 1141():467-504. PubMed ID: 31571172
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
34. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
[TBL] [Abstract][Full Text] [Related]
35. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
36. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
37. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis.
Metrikin DC; Wilson CA; Berkowitz BA; Lam MK; Wood GK; Peshock RM
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1361-70. PubMed ID: 7775114
[TBL] [Abstract][Full Text] [Related]
38. Topography of diabetic macular oedema compared with fluorescein angiography.
Neubauer AS; Chryssafis C; Priglinger SG; Haritoglou C; Thiel M; Welge-Lüssen U; Kampik A; Ulbig MW
Acta Ophthalmol Scand; 2007 Feb; 85(1):32-9. PubMed ID: 17244207
[TBL] [Abstract][Full Text] [Related]
39. N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.
Tawfik A; Mohamed R; Kira D; Alhusban S; Al-Shabrawey M
J Mol Med (Berl); 2021 Jan; 99(1):119-130. PubMed ID: 33159240
[TBL] [Abstract][Full Text] [Related]
40. Rat model for anterior segment intraocular surgery induced blood-retinal barrier breakdown.
Xie MS; Xu GX; Huang Y
Ophthalmologica; 2008; 222(1):42-7. PubMed ID: 18097180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
